Genomic Data and Interpretation Market

The market is favored by the developments in the field of genomics and bioinformatics. Currently, the genomic data analysis and interpretation industry is witnessing an upsurge due to the growing number of genomic research initiatives being undertaken by the developing and developed countries coupled with the decreasing cost of sequencing, resulting in the high demand for software solutions for genomic data analysis. Additionally, high adoption of sequencing instruments by the researchers and clinicians, coupled with the growing prevalence of complex diseases, such as cancer, are some of the critical factors expected to bolster the market growth.
Genomic Data and Interpretation Market contains market size and forecasts of Genomic Data Analysis and Interpretation in Global, including the following market information:
Global Genomic Data Analysis and Interpretation Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Genomic Data Analysis and Interpretation market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Next-Generation Sequencing (NGS) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Genomic Data Analysis and Interpretation include 10x Genomics, Agilent Technologies, ASURAGEN INC, Beijing Genomics Institute (BGI), Genomics, Bio-Rad Laboratories, DNASTAR, F. Hoffmann-La Roche Ltd and Golden Helix, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Genomic Data Analysis and Interpretation companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Genomic Data Analysis and Interpretation Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Genomic Data Analysis and Interpretation Market Segment Percentages, by Type, 2021 (%)
Next-Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Microarray
Other Genomic Platforms
Global Genomic Data Analysis and Interpretation Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Genomic Data Analysis and Interpretation Market Segment Percentages, by Application, 2021 (%)
Research and Academic Institutions
Biotechnology and Biopharmaceutical Companies
Hospitals and Diagnostic Laboratories
Contract Research Organizations
Forensic Laboratories
Other End Users
Global Genomic Data Analysis and Interpretation Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Genomic Data Analysis and Interpretation Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Genomic Data Analysis and Interpretation revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Genomic Data Analysis and Interpretation revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
10x Genomics
Agilent Technologies
ASURAGEN INC
Beijing Genomics Institute (BGI)
Genomics
Bio-Rad Laboratories
DNASTAR
F. Hoffmann-La Roche Ltd
Golden Helix
Illumina
Oxford Nanopore Technologies
Pacific Biosciences of California
Partek
QIAGEN N.V.
SoftGenetics LLC
Thermo Fisher Scientific Inc.